References
Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics 1998. CA Cancer J Clin 1998;48:6–9.
Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. New Engl J Med 1999;340:825–831.
Nigro JJ, Hagen JA, DeMeester TR, et al. Occult esophageal adenocarcinoma: Extent of disease and implications for effective therapy. Ann Surg 1999;230:433–440.
van SandickJW, van Lanschot JJB, Kuiken BW, et al. Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma. Gut 1998;43:216–222.
Sibille A, Lambert R, Souquet J-C, et al. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995;108:337–344.
Overholt BF, Panjehpour M. Barrett’s esophagus: Photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa and treatment of superficial esophageal cancer. Gastrointest Endosc 1995;42:64–70.
Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 2000; 118:670–677.
Swisher SG, DeFord L, Marriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000; 119:1126–1134.
Clark GW, Peters JH, Ireland AP, et al. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 1994;58:646–653.
Hagen JA, DeMeester TR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg 2001;234:520–531.
Badwe RA, Sharma V, Bhansali MS, et al. The quality of swallowing for patients with esophageal carcinoma. A randomized trial comparing surgery with radiotherapy. Cancer 1999;85:763–768.
Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: Clinical experience and refinements. Ann Surg 1999;230:392–403.
GignouxM, Roussel A, Paillot B, et al. The value of preoperative radiotherapy in esophageal cancer: Results of a study of the EORTC. World J Surg 1987;11:426–432.
French University Association for Surgical Research, Tiniere P, Hay JM, Fingerhut A, Fagniez PL. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991;173:123–130.
Fok M, Sham JST, Choy D, et al. Postoperative radiotherapy for carcinoma of the esophagus: A prospective randomized controlled study. Surgery 1993; 113:138–147.
Kelson DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979–1984.
Le Prise E, Etienne P, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779–1784.
Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994;41:391–393.
Urba S, Orringer M, Turrisi A, et al. A randomized trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable esophageal cancer [abstr]. Proc Am Soc Clin Oncol 1997;16:277a.
Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462–467.
Bossett JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 1997;337:161–167.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Peters, J.H. Surgical treatment of esophageal adenocarcinoma: Concepts in evolution. J Gastrointest Surg 6, 518–521 (2002). https://doi.org/10.1016/S1091-255X(02)00025-2
Issue Date:
DOI: https://doi.org/10.1016/S1091-255X(02)00025-2